help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ishigaki, K.
Right arrow Articles by Yamashita, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ishigaki, K.
Right arrow Articles by Yamashita, S.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Medline Plus Health Information
*Thyroid Cancer
The Journal of Clinical Endocrinology & Metabolism Vol. 87, No. 7 3433-3440
Copyright © 2002 by The Endocrine Society


Other Original Articles

Aberrant Localization of ß-Catenin Correlates with Overexpression of Its Target Gene in Human Papillary Thyroid Cancer

Katsu Ishigaki, Hiroyuki Namba, Masahiro Nakashima, Toshiyuki Nakayama, Norisato Mitsutake, Tomayoshi Hayashi, Shigeto Maeda, Makoto Ichinose, Takashi Kanematsu and Shunichi Yamashita

Department of Molecular Medicine (K.I., H.N., N.M., S.Y.), Tissue and Histopathology Section (M.N.), Division of Scientific Data Registry, Department of Molecular Pathology, Atomic Bomb Disease Institute (T.N.), Departments of Pathology (T.H.) and Surgery II (K.I., S.M., T.K.), Nagasaki University School of Medicine, Nagasaki 852-8523, Japan; and Department of Nutrition and Health Sciences (M.I.), Siebold University of Nagasaki, Nagayo 851-2195, Japan

Address all correspondence and requests for reprints to: A/Prof. Hiroyuki Namba, M.D., Department of Molecular Medicine, Atomic Bomb Disease Institute, Nagasaki University School of Medicine, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan. E-mail: . namba{at}net.nagasaki-u.ac.jp

Abstract

Alterations of the Wnt/ß-catenin signaling pathway are known to occur in mutations of the component genes such as APC, Axin, and ß-catenin, and play a pathogenetic role in tumorigenesis. Activated Wnt signaling stabilizes ß-catenin, which associates with T cell factor, resulting in transactivation of the downstream target genes including c-myc and cyclin D1. To investigate the involvement of Wnt/ß-catenin signaling pathway in thyroid tumorigenesis, we analyzed its activation and localization in 5 human thyroid cancer cell lines and 132 thyroid tumor tissue samples. Dislocalization of ß-catenin was observed in all cell lines. Constitutive activation of T cell factor in two of four thyroid cancer cell lines was observed using reporter gene assay. Furthermore, high expression levels of c-Myc and cyclin D1 were observed in cell lines that showed cytoplasmic or nuclear accumulation of ß-catenin. In 132 paraffin-embedded thyroid carcinoma tissue samples, cytoplasmic ß-catenin was immunohistochemically observed in 52 out of 78 (67%) papillary thyroid cancers, but only in 3 of 34 (9%) follicular adenomas and 5 of 20 (25%) follicular cancers. Cytoplasmic localization of ß-catenin significantly correlated with overexpression of cyclin D1 in papillary carcinomas. Our results suggest that aberrant activation of Wnt/ß-catenin signaling is strongly involved in thyroid tumorigenesis.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
A. S. Rao, N. Kremenevskaja, R. von Wasielewski, V. Jakubcakova, S. Kant, J. Resch, and G. Brabant
Wnt/{beta}-Catenin Signaling Mediates Antineoplastic Effects of Imatinib Mesylate (Gleevec) in Anaplastic Thyroid Cancer
J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 159 - 168.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
A S Rao, N Kremenevskaja, J Resch, and G Brabant
Lithium stimulates proliferation in cultured thyrocytes by activating Wnt/{beta}-catenin signalling
Eur. J. Endocrinol., December 1, 2005; 153(6): 929 - 938.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
W. Liu, S. L. Asa, and S. Ezzat
1{alpha},25-Dihydroxyvitamin D3 Targets PTEN-Dependent Fibronectin Expression to Restore Thyroid Cancer Cell Adhesiveness
Mol. Endocrinol., September 1, 2005; 19(9): 2349 - 2357.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
H. Ying, H. Suzuki, H. Furumoto, R. Walker, P. Meltzer, M. C. Willingham, and S.-Y. Cheng
Alterations in genomic profiles during tumor progression in a mouse model of follicular thyroid carcinoma
Carcinogenesis, September 1, 2003; 24(9): 1467 - 1479.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2002 by The Endocrine Society